Cargando…
TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway
Cisplatin resistance along with chemotherapy-induced neuropathic pain is an important cause of treatment failure for many cancer types and represents an unmet clinical need. Therefore, future studies should provide evidence regarding the mechanisms of potential targets that can overcome the resistan...
Autores principales: | Oh, Se Jin, Lim, Ji Yeon, Son, Min Kyu, Ahn, Jun Hyeok, Song, Kwon-Ho, Lee, Hyo-Jung, Kim, Suyeon, Cho, Eun Ho, Chung, Joon-Yong, Cho, Hanbyoul, Kim, Hyosun, Kim, Jae-Hoon, Park, Jooyoung, Choi, Jungmin, Hwang, Sun Wook, Kim, Tae Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172196/ https://www.ncbi.nlm.nih.gov/pubmed/37165076 http://dx.doi.org/10.1038/s41467-023-38318-7 |
Ejemplares similares
-
Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
por: Kwon, Yoojung, et al.
Publicado: (2019) -
NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59
por: Son, Sung Wook, et al.
Publicado: (2022) -
API5 induces cisplatin resistance through FGFR signaling in human cancer cells
por: Jang, Han Sol, et al.
Publicado: (2017) -
RNase H is an exo- and endoribonuclease with asymmetric directionality, depending on the binding mode to the structural variants of RNA:DNA hybrids
por: Lee, Hyunjee, et al.
Publicado: (2021) -
Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
por: Kim, Kidong, et al.
Publicado: (2021)